Invitro Maturation of Oocytes for Patients With Polycystic Ovaries

N/AUnknownNCT00631982

Assaf-Harofeh Medical Center30 enrolled

Overview

In vitro maturation of oocytes after minimal gonadotropin stimulation in patients with polycystic ovaries, to prevent cases of ovarian hyperstimulation.

Study Type

INTERVENTIONAL

Allocation

Purpose

TREATMENT

Masking

NONE

Enrollment

Conditions

Infertility Polycystic Ovaries

Interventions

in vitro matuartion of oocytesPROCEDURE

in vitro maturation of (immature) oocytes

Eligibility

Sex: FEMALEMin age: 18 YearsMax age: 39 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Polycystic ovaries * Needing IVF for fertility treatment Exclusion Criteria: * Age above 39

Locations (1)

IVF and Infertility Unit, Assaf Harofeh Medical Center

Ẕerifin, Israel

Outcomes

Primary Outcomes

maturation rate,

Time frame: 18 months

Secondary Outcomes

Fertilization rate, pregnancy rate

Time frame: 18 months

Central Contacts

Raphael Ron - El, MD

CONTACT

+972-8-9779005

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.